Elmezzi Graduate School of Molecular Medicine

Private nonprofitSpecial Focus: Medical Schools/CentersGraduate/Professional

—

Fin. Resilience

Resilience score

vs. 95 peers in its group

Elmezzi Graduate School of Molecular Medicine is a private nonprofit institution in Manhasset, NY, classified by Carnegie as “Special Focus: Medical Schools/Centers.”

It is benchmarked here against 95 peer institutions (Special Focus: Medical Schools/Centers · Private nonprofit).

Its strongest standing relative to peers is full-time faculty share (100%, 100th percentile).

Its weakest is months of operating cushion (0 mo).

Peer group

Special Focus: Medical Schools/Centers · Private nonprofit

95 institutions

No cross-metric risk flags triggered.

Policy & demographic exposure

How exposed Elmezzi Graduate School of Molecular Medicine is to the structural shifts reshaping higher ed: a composite structural-risk index plus the 2025 federal budget law’s endowment excise tax and Grad PLUS elimination and the demographic enrollment cliff. Only signals that apply to this institution are shown.

Structural risk index

Elevated

Enrollment cliff (home state)

-27%

Severe decline

Indicative signals, not forecasts — see each metric’s definition and the methodology. Endowment-tax and Grad PLUS figures appear only where the institution is actually exposed; “nationally” compares against all schools that report each signal.

Turn these signals into action

Seeing exposure is step one. Ibex builds AI agents that monitor and act on exactly these pressures — explore an interactive demo. Live demos run real workflows; the rest are working mockups we build to your institution’s data.

Market Intelligence Agentlive demo AI Recruiter Agent

Financial Health Index

2.3

on a −4 to 10 scale

Financial Health IndexWatch

NACUBO Composite Financial Index — the balance-sheet health score accreditors and institutional boards use to gauge financial health; bond-rating agencies track similar ratios. 28th percentile of 95 peers. Carries little or no plant debt, so the viability ratio is excluded and weights re-normalized.

Primary reserve 55%0 mo

Return on net assets 30%5.1%

Operating result 15%17.2%

Composite of four ratios on a strength-factor scale (−4 weak → 10 strong): below 3 falls short of the threshold for financial health, below 1 signals acute stress, and above 6 is strong. Computed from IPEDS FY2022-23, the most recent finance release (it lags the current year by 2–3 years). Branch campuses that report finances at a parent/system level can show distorted ratios. For informational benchmarking, not a credit rating or financial advice.

Revenue composition

Where the money comes from $4M total revenue · IPEDS FY2022-23

Private gifts & grants is the largest single source at 50% of revenue.

Private gifts & grants50.0%

Investment return50.0%

Where each dollar of revenue comes from, as a share of total positive revenue. Sources are standardized across public (GASB) and private (FASB) reporting; a net investment loss in a down market is shown as 0% and excluded from the mix.

Financial Health

Endowment (end of year)

Strong

$31.3M

78th percentile in peer grouppeer median $9.4M

Avg monthly faculty salary

Strong

$19,293

99th percentile in peer grouppeer median $8,016

Average monthly salary of full-time faculty, as reported to IPEDS.

Operating margin

Strong

63.7%

99th percentile in peer grouppeer median 0.3%

Net surplus as a share of total revenue (IPEDS FY2022-23): (total revenues − total expenses) ÷ total revenues. A surplus above 4% is strong; a thin surplus near 0% leaves little margin for shocks.

Tuition dependency

1st percentile in peer grouppeer median 78.3%

Tuition & fees as a share of total revenue (IPEDS FY2022-23). Higher = more exposed to enrollment swings.

State appropriations share

96th percentile in peer grouppeer median 0%

State appropriations as a share of total revenue (IPEDS FY2022-23). Material for public institutions; ~0 for private.

Months of operating cushion

Thin

0 mo

19th percentile in peer grouppeer median 10 mo

How many months of operating expenses the institution could cover from expendable reserves (IPEDS FY2022-23 primary reserve ratio × 12). About 5 months — one semester — is the accreditor benchmark for solid footing; below ~3 months is thin. A negative figure means expendable reserves are themselves negative.

Return on net assets

Strong

5.1%

71st percentile in peer grouppeer median 1.5%

Change in total net assets ÷ net assets (IPEDS FY2022-23) — whether the institution grew wealthier over the year. 2–4% is adequate; above 4% is strong.

Endowment per FTE student

Strong

$3.5M

100th percentile in peer grouppeer median $13,081

End-of-year endowment ÷ 12-month FTE enrollment — endowment wealth per full-time-equivalent student. The FTE-correct companion to endowment-per-undergraduate; FTE counts graduate and part-time load, so research universities look less wealthy on this basis than on a headcount basis.

Structural risk index

Elevated

— percentile in peer group

An indicative 0–100 structural-risk index (higher = more pressure), an equal-weight blend of the stress signals we measure: thin or negative operating margin, low months of operating cushion, high tuition dependency, and a shrinking home-state high-school-graduate pipeline (enrollment cliff). Averaged over whichever signals are available (at least two required). It screens for the financial and demographic pressures that precede closures and mergers — a directional indicator, NOT a prediction that any institution will close, and not a credit rating.

Enrollment & Pipeline

12-month FTE enrollment

1st percentile in peer grouppeer median 492

Full-time-equivalent enrollment over the full 12-month year (IPEDS 12-month enrollment, 2022-23). Counts part-time students at their fractional load, so it runs above fall full-time headcount and is the denominator used for per-student finance measures.

Enrollment cliff (home state)

Severe decline

-27%

— percentile in peer group

Projected change in the number of high-school graduates in the institution's HOME STATE from the class of 2025 (the national peak) to 2041, per WICHE's Knocking at the College Door, 11th Edition (Dec 2024). The 'enrollment cliff' is the post-2008 birth decline reaching college age; the U.S. total is projected to fall about 13% over this window. A college recruits from many states, so its home-state projection is an indicative directional signal of feeder-market pressure, not a forecast of that institution's own enrollment.

Student Outcomes & Risk

Full-time faculty share

Strong

100%

100th percentile in peer grouppeer median 62.7%

Top fields of study (all levels)

Elmezzi Graduate School of Molecular Medicine’s largest fields by completions, with graduate earnings (4 years out) and debt benchmarked against the same field at its peer group. Sparklines show the 8-year completions trend.

Field	Completions / yr	Median earnings, 4 yrs out	Median debt	Earnings premium	Risk score
Biological & Biomedical Sciences	2	—	—	—	High · 78

Earnings-premium status is an indicative estimate: median graduate earnings four years out vs the NY state median earnings of a high-school graduate (undergraduate credentials) or a bachelor’s-degree holder (graduate credentials) from the U.S. Census Bureau’s American Community Survey (2022 ACS 5-year). The official U.S. Department of Education determination uses its own cohort definition and may differ.

The risk score (0–100) is an indicative blend of earnings-premium margin and the five-year completions trend—higher means a field pays closer to (or below) the benchmark and is shrinking. A directional screen, not an official determination.

See the interactive dashboard for all fields and credential levels (associate through doctoral). Source: College Scorecard Field of Study.

Frequently asked

How financially healthy is Elmezzi Graduate School of Molecular Medicine?

On the NACUBO Composite Financial Index — the −4 to 10 balance-sheet score accreditors and institutional boards use — Elmezzi Graduate School of Molecular Medicine scores 2.3 (Watch), computed from its IPEDS FY2022-23 finances. This is informational benchmarking, not a credit rating.

Which schools are Elmezzi Graduate School of Molecular Medicine's peers?

Elmezzi Graduate School of Molecular Medicine is benchmarked against 95 institutions in the Special Focus: Medical Schools/Centers · Private nonprofit peer group; all percentiles and medians on this page are computed within that group.

Compare with peers

Academy for Five Element Acupuncture Academy of Chinese Culture and Health Sciences Acupuncture and Integrative Medicine College-Berkeley Adler Graduate School Appalachian College of Pharmacy Atlantic Institute of Oriental Medicine

Explore Elmezzi Graduate School of Molecular Medicine interactively

Open the full dashboard to switch peer views, hover trends, and compare head-to-head.

Open in dashboard

Want a custom dashboard for Elmezzi Graduate School of Molecular Medicine?

We build tailored intelligence dashboards — Elmezzi Graduate School of Molecular Medicine and the peer set you choose, the metrics and risk signals your team cares about, kept current and delivered to you. Tell us what you’d want to track and a specialist will scope it with you.

Request a custom dashboard

Source: U.S. Department of Education — College Scorecard & IPEDS (most recent releases), with the U.S. Census Bureau (ACS), the U.S. Bureau of Labor Statistics (Employment Projections, field-demand outlook) and WICHE (enrollment-cliff projections). Figures lag the current academic year by roughly two to three years. Percentiles and medians are computed within the institution's peer group. Financial Resilience is a transparent composite — see each component above. Compiled by Ibex Insights.